Tanguy, M., Cabel, L., Berger, F., Pierga, J., Savignoni, A., & Bidard, F. (2018). Cdk4/6 inhibitors and overall survival: Power of first-line trials in metastatic breast cancer. NPJ Breast Cancer.
Citação norma ChicagoTanguy, Marie-Laure, Luc Cabel, Fréderique Berger, Jean-Yves Pierga, Alexia Savignoni, and Francois-Clement Bidard. "Cdk4/6 Inhibitors and Overall Survival: Power of First-line Trials in Metastatic Breast Cancer." NPJ Breast Cancer 2018.
Citação norma MLATanguy, Marie-Laure, et al. "Cdk4/6 Inhibitors and Overall Survival: Power of First-line Trials in Metastatic Breast Cancer." NPJ Breast Cancer 2018.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.